Product Details

Reality of costs and impact rain on Sunshine Act

As pharmaceutical companies have just finished submitting first-period reports detailing their financial relationships with physicians and teaching hospitals as required under the Open Payments national disclosure program, also referred to as the Physician Payments Sunshine Act, most have found the time and resources needed to comply with the law are significantly higher than originally anticipated.

Cloud computing expanding into all areas of clinical trial conduct

Mention cloud computing for clinical trials and you’re likely to hear how it has begun to lower skyrocketing R&D costs while providing ease of use, rapid scalability, flexibility and availability when compared to other storage and processing options.

Also in this issue:

• Barriers to going paperless tumbling down
• Improving the sponsor-investigator relationship
• Regulatory Update
• Month in Review
• Study Lead Opportunities
• FDA Actions
• New Drugs in the Pipeline